Pfizer Inc.
PFE
$26.61
$0.030.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -146.53% | -- | -- | 623.66% | -90.82% |
| Total Depreciation and Amortization | 0.12% | -- | -- | -9.73% | 2.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 767.74% | -- | -- | -120.48% | 523.61% |
| Change in Net Operating Assets | 4,516.67% | -- | -- | -165.58% | 232.88% |
| Cash from Operations | 16.19% | -- | -- | -65.26% | 0.10% |
| Capital Expenditure | -40.37% | -- | -- | 38.50% | -40.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.95% | -- | -- | 643.63% | 49.79% |
| Cash from Investing | -152.92% | -- | -- | 301.73% | 21.10% |
| Total Debt Issued | -- | -- | -- | -- | -66.13% |
| Total Debt Repaid | -48,533.33% | -- | -- | 29.49% | 21.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.04% | -- | -- | -2.39% | 0.00% |
| Other Financing Activities | -12.82% | -- | -- | -2,442.86% | -133.33% |
| Cash from Financing | 124.06% | -- | -- | -2.21% | -10.31% |
| Foreign Exchange rate Adjustments | 150.00% | -- | -- | 75.86% | -422.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.33% | -- | -- | 931.11% | -255.17% |